VitalhubFRA:6OVA -0.90%70 3-Year ROIIC % is 5.06 as of Dec. 2025, which is 4% above its 10-year median of 4.85. GuruFocus rates FRA:6OVA with a GF Score™ of 70/100 and a GF Value™ of €6.90 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 621 Healthcare Providers & Services companies, Vitalhub ranks better than 52.98% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Vitalhub's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 5.06%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Vitalhub's 3-Year ROIIC % or its related term are showing as below:
FRA:6OVA's 3-Year ROIIC % is ranked better than 52.98% of 621
companies
in the Healthcare Providers & Services industry
Industry Median: 3.46
vs FRA:6OVA: 5.06
Vitalhub (FRA:6OVA) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Vitalhub 3-Year ROIIC % Related Terms
Vitalhub 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Vitalhub's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:6OVA vs VEEV, BTSG, TEM: 3-Year ROIIC % Comparison
For the Health Information Services subindustry, Vitalhub's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vitalhub 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vitalhub's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Vitalhub's 3-Year ROIIC % falls into.
Vitalhub's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 7.533 (Dec. 2025) - 3.01158 (Dec. 2022) )
/
( 153.547 (Dec. 2025) - 64.884 (Dec. 2022) )
=
4.52142
/
88.663
=
5.10%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Vitalhub (FRA:6OVA) has a 3-Year ROIIC % of 5.06 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Vitalhub and its competitors. This is near median its historical median of 4.85. Over the past decade, Vitalhub's 3-Year ROIIC % has ranged from 0.92 to 12.00. According to the industry distribution chart, Vitalhub ranks #292 out of 621 companies in the Healthcare Providers & Services industry, placing it in the top 47%.
Is Vitalhub's 3-Year ROIIC % too high?
Vitalhub's current 3-Year ROIIC % of 5.06 is near median its 10-year median of 4.85. Over the past 10 years, this metric has ranged from a low of 0.92 to a high of 12.00. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.46. Vitalhub's value of 5.06 is 46.2% above this industry median. Based on the distribution chart, Vitalhub ranks #292 out of 621 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Vitalhub has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vitalhub's 3-Year ROIIC % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Vitalhub ranks #292 out of 621 companies for 3-Year ROIIC %. This puts Vitalhub in the upper half of its industry. The industry median 3-Year ROIIC % is 3.46. Vitalhub's value of 5.06 is 46.2% above this benchmark. Historically, Vitalhub's own 3-Year ROIIC % has ranged from 0.92 to 12.00 over the past decade. While the company's 10-year median is 4.85 vs. the industry median of 3.46, Vitalhub has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.46, based on 621 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vitalhub's current 3-Year ROIIC % of 5.06 is 46.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Vitalhub and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitalhub's current 3-Year ROIIC % is 5.06, which is near median its own 10-year median of 4.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitalhub stock overvalued right now?
Based on GuruFocus' analysis, Vitalhub (FRA:6OVA) is currently considered Possible Value Trap. The stock's GF Value™ is €6.90, compared to a current price of €4.40 — trading 36.2% below its estimated fair value. The current 3-Year ROIIC % is 5.06, which is near median its 10-year median of 4.85 and 46.2% above the Healthcare Providers & Services industry median of 3.46. Vitalhub's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Vitalhub (FRA:6OVA), the current 3-Year ROIIC % is 5.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vitalhub (FRA:6OVA) Overvalued in 2026?
Based on GuruFocus' analysis, Vitalhub stock appears to be undervalued.
The current stock price of €4.40 is trading 36.2% below its estimated GF Value™ of €6.90.
GuruFocus considers Vitalhub to be Possible Value Trap.
Key valuation signals for FRA:6OVA:
3-Year ROIIC %: 5.06 (near median its 10-year median of 4.85)
GF Value™: €6.90 vs. price of €4.40 (36.2% below fair value)
Industry Position: 46.2% above the Healthcare Providers & Services median (#292 of 621)
No single metric tells the full story. See the FRA:6OVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vitalhub Corp provides technology to Health and Human Service providers, including Hospitals, Regional Health Authorities, Mental Health, Long-Term Care, Home Health, and Community and Social Services. Vitalhub solutions span the categories of Electronic Health Records (EHR), Case Management, Care Coordination, Patient Flow, Operational Visibility, and Mobile Apps. It operates in one segment for its operations related to healthcare information systems in the mental health, long-term care, community health service, and hospital sectors. Geographically, it's available in Canada, the United Kingdom, Australia, the USA, Western Asia, and the Rest of the world, and the majority of the revenue comes from the United Kingdom.
70GF Score
Get the complete analysis for FRA:6OVA
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:6OVA has been successfully added to your 
